News About: Goverment
Fostering plans for medical institution over hospital level
The MOHW plans to establish mid and long-term consolidated fostering programs for the medical institutions of over hospital level by setting new functions and developing directions.
To this end the MOHW is going to...
Incentives for physician's prescriptions in generic name.
While the MOHW is on the way of legislating the physician's prescription written in generic names, the KPhA is now suggesting an incentive plan for physicians when prescribing in generic names in order to minimize a p...
Prescription by generic name in hot issue
With the recent remarks of Minister Lee Tai-bok of Health and Welfare on the promotion of 'prescription by genetic name', the medical and pharmaceutical associations have disclosed varying views.
1. Ministry of Hea...
Probation times for NHI drug price related ordinance.
The MOHW intends to provide enough probation times to the relevant authorities such as retail pharmacies and medical institutions before implementing the revised lists of the NHI reimbursement and non-reimbursement dr...
Compulsory enforcement of bioequivalance test eyed
The Korea Food and Drug Administration (KFDA) says that it will positively contemplate the mandatory bioequivalance test and drug re-evaluation project on any new licensed items containing ingredients which will be su...
Duty pharmacy to launch from July by each county.
The MOHW announced that a duty pharmacy operation up to the late mid-night (2 a.m.) would be implemented from coming July in order to provide conveniencies to the people.
The duty pharmacy operation will be appoint...
Public health centers involved in the prescription of high-priced drugs
The MOHW announced it discovered some health centers that have been engaged in the practices of prescribing high-priced drugs for outpatients as a result of its inspection on 23 public centers from April 17 through Ap...
Special Committee for Pharmaceutical Affairs System unveils 31 drug related subjects
In its first meeting, the Special Committee for Pharmaceutical Affairs System Improvement, a presidential consultative body, has recently announced that 31 subjects including eradication of illegal prescription dealin...
New product licenses total 19
The Korea Food and Drug Administration announced that licenses for new products totaled 19 as of the end of last April. Details:
Status of new products
Product Remarks
Company
Indications
...
Interim injunction against bottom level of NHI drug pricing policy.
The KPMA (Chairman: Kim Jung-soo) stood a harsh stance against the MOHW's NHI drug pricing policy and decided to take a legal action.
The MOHW earlier announced in May 3 the drug price slashing measures including t...
